Bio-based 1,3-Propanediol MarketSize, Share & Industry Analysis, 2026-2034By Production TechnologyBy FeedstockBy GradeBy Purity LevelBy ApplicationBy End-use IndustryBy Product PositioningBy Producer TypeBy Production Capacity BandBy Sales ChannelBy Packaging Form
Full title & scope — all 11 axes with their segments
Bio-based 1,3-Propanediol Market Size, Share & Industry Analysis, By Production Technology (Microbial Fermentation, Fermentation with Downstream Purification, Enzymatic and Bio-catalytic Conversion, Hybrid Bio-chemical Routes), By Feedstock (Corn-derived Glucose, Crude and Refined Glycerol, Sugarcane and Cassava Sugars, Lignocellulosic Sugars, Palm-based Glycerol), By Grade (Polymer Grade, Cosmetic and Personal Care Grade, Industrial Grade, Food and Pharmaceutical Grade, Laboratory and Reagent Grade), By Purity Level (Below 99.0%, 99.0% to 99.7%, Above 99.7%), By Application (Polytrimethylene Terephthalate, Cosmetics and Personal Care, Polyurethanes, Industrial Chemicals, Polyester Polyols and Resins, Food and Pharmaceutical Use, Others), By End-use Industry (Textiles and Apparel, Personal Care and Beauty, Automotive, Paints, Coatings and Inks, Packaging, Household and Industrial Cleaning, Pharmaceuticals and Food), By Product Positioning (Fully Bio-based PDO, Partially Bio-based PDO, Drop-in Replacement for Petro-based Glycols), By Producer Type (Integrated Joint Ventures, Independent Bio-PDO Producers, Corn Processors and Agri-industrial Producers, Specialty Chemical Companies), By Production Capacity Band (Below 10,000 Tons per Year, 10,000 to 50,000 Tons per Year, Above 50,000 Tons per Year), By Sales Channel (Direct Sales to Manufacturers, Chemical Distributors, Online and Catalogue Suppliers, Long-term Supply Contracts), By Packaging Form (Bulk Tanker, ISO Tank and IBC, Drums, Small Packs), and Regional Forecast, 2026-2034
Market outlook, key takeaways, drivers and challenges for the report period.
- 01By Production TechnologyMicrobial Fermentation · Fermentation with Downstream Purification · Enzymatic and Bio-catalytic Conversion
- 02By FeedstockCorn-derived Glucose · Crude and Refined Glycerol · Sugarcane and Cassava Sugars
- 03By GradePolymer Grade · Cosmetic and Personal Care Grade · Industrial Grade
- 04By Purity LevelBelow 99.0% · 99.0% to 99.7% · Above 99.7%
- 05By ApplicationPolytrimethylene Terephthalate · Cosmetics and Personal Care · Polyurethanes
- 06By End-use IndustryTextiles and Apparel · Personal Care and Beauty · Automotive
- 07By Product PositioningFully Bio-based PDO · Partially Bio-based PDO · Drop-in Replacement for Petro-based Glycols
- 08By Producer TypeIntegrated Joint Ventures · Independent Bio-PDO Producers · Corn Processors and Agri-industrial Producers
- 09By Production Capacity BandBelow 10,000 Tons per Year · 10,000 to 50,000 Tons per Year · Above 50,000 Tons per Year
- 10By Sales ChannelDirect Sales to Manufacturers · Chemical Distributors · Online and Catalogue Suppliers
- 11By Packaging FormBulk Tanker · ISO Tank and IBC · Drums
- 12By Region
Market Analysis & Outlook
Bio-based propanediol (PDO) is a short-chain diol made by fermenting or enzymatically converting renewable sugars or glycerol, as an alternative to petrochemical routes. It is sold in polymer, cosmetic, industrial, food and pharmaceutical grades, in packaged forms from bulk tankers to small packs. Buyers are polymer and fibre makers, personal care and cosmetic formulators, polyurethane and resin producers, and industrial chemical manufacturers.
The global bio-based 1,3-propanediol market stood at USD 515 million in 2025. A forecast-period rate of 6.95% takes it to USD 940 million by 2034, and the study reports every year in between, passing USD 372 million in 2020, USD 485 million in 2024, USD 549 million in 2026 and USD 715 million in 2030.
On the production technology axis, growth rates run from 5.66% for Microbial Fermentation up to 10.62% for Hybrid Bio-chemical Routes. Microbial Fermentation carries the volume: USD 298.7 million and 58% of revenue in 2025, USD 488.8 million and 52% in 2034. The lines gaining share are Fermentation with Downstream Purification, Enzymatic and Bio-catalytic Conversion and Hybrid Bio-chemical Routes. Microbial Fermentation lose share without losing revenue.
By feedstock, Corn-derived Glucose accounts for 52% of 2025 revenue at USD 267.8 million, reaching USD 432.4 million and 46% by 2034. Lignocellulosic Sugars grows faster at 15.47% against 5.47%, moving from 4% of revenue to 8% by 2034. This axis divides the same revenue as the production technology split instead of adding to it, so the two are read together and never summed.
Geographically, 38% of 2025 revenue sits in Asia Pacific (USD 195.7 million rising to USD 404.2 million) ahead of North America at 27% and USD 139.05 million. Middle East and Africa is smallest, at 5%. Asia Pacific gain share across the period, so growth is not distributed evenly between regions.
Behind these figures sit five regions, four production technology lines and eleven segmentation axes, each reported for every year from 2020 to 2034. The headline 2025 value is triangulated from published sources and category proxies, with no independently sourced count behind it, and the same applies to the segment, regional and country breakdowns drawn from it.
Market Size, 2020–2034
USD MillionRevenue in USD Million. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- Revenue grows from USD 515 million in 2025 to USD 940 million in 2034, a compound annual rate of 6.95%, having reached USD 485 million in 2024 from USD 372 million in 2020.
- Microbial Fermentation is the largest production technology line at USD 298.7 million in 2025, a 58% share, reaching USD 488.8 million and 52% of revenue by 2034.
- Fastest growth on the production technology axis belongs to Hybrid Bio-chemical Routes: 10.62% a year, USD 41.2 million to USD 103.4 million, and a share moving from 8% to 11%.
- Against a base case of USD 940 million in 2034, the study also reports a bear case at USD 821 million and a bull case at USD 1036 million, with the assumptions behind each set out separately.
- Asia Pacific holds 38% of global revenue in 2025 at USD 195.7 million, the largest of the five regions tracked, and reaches USD 404.2 million by 2034.
- China accounts for 53.65% of Asia Pacific in the base year, worth USD 105 million in 2025 and reaching USD 233 million by 2034, the worked country example carried through that region's chapters.
- Every line on all eleven segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.
Market Trends
Revenue Share, By production technology
Base year 2025Microbial Fermentation leads with 58.0% of production technology segment revenue.
Share of production technology segment revenue, most recent base year.
The global bio-based 1,3-propanediol market is shaped over 2026-2034 by three measurable movements: a change in the production technology mix, a shift in where revenue sits geographically, and the 6.95% rate carrying the total.
None of them reverses the market's direction. Every line and every region grows in absolute terms across the period; the movement is in which of them captures the revenue added.
Hybrid Bio-chemical Routes outpaces Microbial Fermentation. The widest spread on the production technology axis is between Hybrid Bio-chemical Routes at 10.62% and Microbial Fermentation at 5.66%. Over the forecast period that moves Hybrid Bio-chemical Routes from 8% of revenue to 11%, and Microbial Fermentation from 58% to 52%. Revenue rises on both sides; USD 41.2 million to USD 103.4 million and USD 298.7 million to USD 488.8 million respectively, so this is a change in composition, not a contraction, and one forecast window is long enough for it to matter.
The regional balance moves. Asia Pacific moves from 38% of revenue in 2025 to 43% in 2034, worth USD 195.7 million rising to USD 404.2 million. The remaining regions grow in absolute terms while giving up share: North America at 27% moving to 25%, Europe at 24% moving to 22%, Latin America at 6% moving to 5.6%, Middle East and Africa at 5% moving to 4.4%. Revenue added in this market is therefore concentrating geographically instead of spreading evenly, and a participant weighted toward a share-losing region grows more slowly than the market even while its own revenue climbs.
Fifteen years without a discontinuity. Year by year the total runs USD 372 million in 2020, USD 485 million in 2024, USD 515 million in 2025, USD 549 million in 2026, USD 715 million in 2030 and USD 940 million in 2034. No year breaks the trajectory, and the 6.95% forecast rate compares with 6.72% recorded over 2020-2025, a continuation, not an inflection. The risk in the number sits in the mix assumptions, not in whether the market grows at all, which is where the production technology and regional sections come in.
Market Growth Factors
Hybrid Bio-chemical Routes carries the market's growth rate
Market Drivers
3- 01Hybrid Bio-chemical Routes carries the market's growth rate
The fastest line on the production technology axis is Hybrid Bio-chemical Routes, at 10.62% against the market's 6.95%, taking USD 41.2 million to USD 103.4 million and 8% of revenue to 11%. Because the spread to Microbial Fermentation at 5.66% is this wide, the headline 6.95% is a weighted result, not a rate any single line achieves. That makes position on the production technology axis a growth decision, not a product one.
- 02Asia Pacific carries 38% of the base and keeps growing
The largest regional base is Asia Pacific: USD 195.7 million in 2025 at 38% of the global total, USD 404.2 million by 2034 and 43%. Behind it, North America holds 27%; USD 139.05 million rising to USD 235 million. Together the two account for the majority of both the 2025 base and the revenue added by 2034, which is why a regional plan treating all five regions at equal weight misreads where the growth actually lands.
- 03The base has grown every year since 2020
The historical period compounded at 6.72%; USD 372 million in 2020, USD 485 million in 2024 and USD 515 million in 2025. From there the forecast carries 6.95% through to USD 940 million in 2034. Because the growth is already in the record and not only in the projection, the rate is held flat across the forecast instead of ramped, and the risk in the number sits in the mix assumptions, not in whether the market grows at all.
Growth drivers
| # | Growth driver | Impact | Gross contribution (USD Million) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Bio-based content targets in textile and carpet fibres | High | +150 | High | High | Medium |
| 2 | Cosmetic and personal care shift to renewable ingredients | Medium-High | +120 | High | Medium | Medium |
| 3 | New fermentation capacity and yield gains lowering unit cost | Medium-High | +100 | Medium | High | High |
| 4 | Polyurethane and resin demand for bio-based polyols | Medium | +70 | Medium | Medium | Medium |
| 5 | Others | Low | +60 | Low | Low | Low |
| Total | +500 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (USD Million) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Feedstock price volatility | Medium-High | −35 | High | Medium | Medium |
| 2 | Competition from cheaper petro-based diols | Medium | −25 | Medium | Medium | Medium |
| 3 | Concentrated supply and long customer qualification cycles | Low | −15 | Medium | Low | Low |
| Total | −75 | |||||
Drivers contribute 500 USD Million and restraints remove 75 USD Million, a net 425 USD Million, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
Separate the 6.95% into its parts and three show up: an already-large base compounding, the production technology mix moving toward its faster lines, and regional growth landing unevenly.
Restraining Factors
The bear case and what drives it
Market Restraints
2- 01The bear case and what drives it
Feedstock costs stay high, announced capacity is delayed, and buyers return to cheaper petro-based diols in price-sensitive uses. On that assumption 2034 revenue lands at USD 821 million against the USD 940 million base case, from the same USD 515 million 2025 starting point.
- 02Microbial Fermentation holds the blended rate down
Microbial Fermentation carries 58% of 2025 revenue at USD 298.7 million but compounds at 5.66% against 6.95% for the market, taking its share to 52% by 2034 even as revenue rises to USD 488.8 million. Because it carries that much of the base, its pace holds the blended rate down more than any faster line lifts it.
Market Opportunities
Upside case: USD 1036 million by 2034
Market Opportunities
2- 01Upside case: USD 1036 million by 2034
The upside path assumes brand owners in fibres and cosmetics raise bio-based content targets faster, new fermentation plants start on schedule, and yield gains narrow the cost gap to petro-based diols sooner. It ends 2034 at USD 1036 million against a USD 940 million base case, off the same USD 515 million base year.
- 02Hybrid Bio-chemical Routes share moves from 8% to 11%
Hybrid Bio-chemical Routes grows at 10.62% against 6.95% for the market, adding revenue from USD 41.2 million in 2025 to USD 103.4 million in 2034 and taking its share from 8% to 11%. It is the place on this axis where share changes hands at scale, so it is where an entrant can take position without displacing the incumbent in Microbial Fermentation.
Market Challenges
The total depends on a single line
Market Challenges
2- 01The total depends on a single line
Microbial Fermentation is 58% of 2025 revenue at USD 298.7 million and still 52% at USD 488.8 million in 2034. No other single change on the production technology axis moves the total as much as a change in demand for that one line.
- 02China is 53.65% of Asia Pacific
Asia Pacific is worth USD 195.7 million in 2025 and USD 105 million of that is China; 53.65% of the region, reaching USD 233 million in 2034. A regional number that depends this heavily on one country carries that country's specific conditions inside it, which a reader treating the region as diversified would miss.
Segmentation Analysis
11 axesSegmentation runs along eleven axes: production technology, feedstock, grade, purity level, application, end-use industry, product positioning, producer type, production capacity band, sales channel and packaging form. Revenue does not add across them: each is a different cut of the same total.
There are four lines on the production technology axis, and all of them grow in revenue between 2025 and 2034. What separates them is share: three gain it, the other gives it up.
By Production Technology · 4 segments
Hybrid Bio-chemical Routes Outpaces the Axis While Microbial Fermentation Holds the Largest Share
- Largest Microbial Fermentation · 58%
- Fastest Hybrid Bio-chemical Routes · 10.6%
- Moves most Microbial Fermentation · -6 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Microbial Fermentation | $299M | 58% | $489M | 52%-6 | 5.7% |
| Fermentation with Downstream Purification | $124M | 24% | $235M | 25%+1 | 7.5% |
| Enzymatic and Bio-catalytic Conversion | $51.50M | 10% | $113M | 12%+2 | 9.2% |
| Hybrid Bio-chemical Routes | $41.20M | 8% | $103M | 11%+3 | 10.6% |
Microbial fermentation leads because it is the established commercial route, with proven strains, existing plants and the broadest customer qualification. Hybrid bio-chemical routes grow fastest as producers combine biological conversion with chemical steps to raise yield and lower purification cost, and as pilot facilities move into commercial operation. The order does not change: Microbial Fermentation is still largest in 2034, and what moves is how much it holds. Every year of the series is priced on this axis, making it the reference cut for the rest of the report.
By Feedstock · 5 segments
Scale in Corn-derived Glucose and Growth in Lignocellulosic Sugars Define the Feedstock Axis
- Largest Corn-derived Glucose · 52%
- Fastest Lignocellulosic Sugars · 15.5%
- Moves most Corn-derived Glucose · -6 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Corn-derived Glucose | $268M | 52% | $432M | 46%-6 | 5.5% |
| Crude and Refined Glycerol | $113M | 22% | $188M | 20%-2 | 5.8% |
| Sugarcane and Cassava Sugars | $72.10M | 14% | $160M | 17%+3 | 9.3% |
| Lignocellulosic Sugars | $20.60M | 4% | $75.20M | 8%+4 | 15.5% |
| Palm-based Glycerol | $41.20M | 8% | $84.60M | 9%+1 | 8.3% |
Corn-derived glucose leads because the dominant fermentation plants sit next to corn processing, which gives steady supply and settled logistics. Lignocellulosic sugars grow fastest from a small base as producers seek feedstock that avoids food competition and as conversion technology moves from demonstration to commercial plants, supported by sustainability requirements from brand owners. The order does not change: Corn-derived Glucose is still largest in 2034, and what moves is how much it holds.
By Grade · 5 segments
Scale in Polymer Grade and Growth in Food and Pharmaceutical Grade Define the Grade Axis
- Largest Polymer Grade · 55%
- Fastest Food and Pharmaceutical Grade · 10.8%
- Moves most Polymer Grade · -5 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Polymer Grade | $283M | 55% | $470M | 50%-5 | 5.8% |
| Cosmetic and Personal Care Grade | $103M | 20% | $207M | 22%+2 | 8.1% |
| Industrial Grade | $72.10M | 14% | $122M | 13%-1 | 6% |
| Food and Pharmaceutical Grade | $41.20M | 8% | $103M | 11%+3 | 10.8% |
| Laboratory and Reagent Grade | $15.45M | 3% | $37.60M | 4%+1 | 10.4% |
Polymer grade leads because fibre and resin producers consume the largest volumes and buy under long contracts. Food and pharmaceutical grade grows fastest as renewable and natural-origin ingredients gain acceptance in regulated products, where buyers pay for certification and traceability, and as approvals extend to more formulations and regions. Polymer Grade remains the largest line through 2034, so the axis changes in proportion, not in order.
By Purity Level · 3 segments
Above 99.7% Holds the Largest Purity level Share and Is Still the Quickest to Grow
- Largest Above 99.7% · 50%
- Fastest Above 99.7% · 8.1%
- Moves most Above 99.7% · +5 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Below 99.0% | $61.80M | 12% | $84.60M | 9%-3 | 3.5% |
| 99.0% to 99.7% | $196M | 38% | $338M | 36%-2 | 6.3% |
| Above 99.7% | $258M | 50% | $517M | 55%+5 | 8.1% |
The highest purity band leads because polymer synthesis and cosmetic formulation both need low impurity levels for colour, odour and chain length control, so most volume is sold at that specification. The same band grows fastest as fibre and cosmetic buyers tighten specifications and purification capacity expands to meet them. Above 99.7% remains the largest line through 2034, so the axis changes in proportion, not in order.
By Application · 7 segments
By Application
- Largest Polytrimethylene Terephthalate (PTT) · 46%
- Fastest Food and Pharmaceutical Use · 11%
- Moves most Polytrimethylene Terephthalate (PTT) · -4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Polytrimethylene Terephthalate (PTT) | $237M | 46% | $395M | 42%-4 | 5.8% |
| Cosmetics and Personal Care | $97.85M | 19% | $188M | 20%+1 | 7.5% |
| Polyurethanes | $51.50M | 10% | $103M | 11%+1 | 8.1% |
| Industrial Chemicals | $46.35M | 9% | $75.20M | 8%-1 | 5.5% |
| Polyester Polyols and Resins | $36.05M | 7% | $75.20M | 8%+1 | 8.5% |
| Food and Pharmaceutical Use | $25.75M | 5% | $65.80M | 7%+2 | 11% |
| Others | $20.60M | 4% | $37.60M | 4% | 6.9% |
2025 to 2034 revenue and share by line: Polytrimethylene Terephthalate (PTT) USD 236.9 million to USD 394.8 million (46% to 42%), Cosmetics and Personal Care USD 97.85 million to USD 188 million (19% to 20%), Polyurethanes USD 51.5 million to USD 103.4 million (10% to 11%), Industrial Chemicals USD 46.35 million to USD 75.2 million (9% to 8%), Polyester Polyols and Resins USD 36.05 million to USD 75.2 million (7% to 8%), Food and Pharmaceutical Use USD 25.75 million to USD 65.8 million (5% to 7%), Others USD 20.6 million to USD 37.6 million (4% to 4%). Polytrimethylene Terephthalate (PTT) Held the Dominant Share of the Application Segment in 2025 Polytrimethylene terephthalate leads because it is the largest single use, supplying fibres for apparel and carpet, with established supply agreements. Food and pharmaceutical use grows fastest from a small base as bio-based ingredients enter regulated formulations and as approvals widen, while cosmetics add steady volume through reformulation toward renewable ingredients. By 2034 Polytrimethylene Terephthalate (PTT) is still ahead, making this a shift in weight, not a change of leader.
By End-use Industry · 7 segments
By End-use Industry
- Largest Textiles and Apparel · 34%
- Fastest Pharmaceuticals and Food · 8.5%
- Moves most Textiles and Apparel · -3 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Textiles and Apparel | $175M | 34% | $291M | 31%-3 | 5.8% |
| Personal Care and Beauty | $103M | 20% | $197M | 21%+1 | 7.5% |
| Automotive | $61.80M | 12% | $122M | 13%+1 | 7.9% |
| Paints, Coatings and Inks | $51.50M | 10% | $94M | 10% | 6.9% |
| Packaging | $46.35M | 9% | $94M | 10%+1 | 8.2% |
| Household and Industrial Cleaning | $41.20M | 8% | $65.80M | 7%-1 | 5.3% |
| Pharmaceuticals and Food | $36.05M | 7% | $75.20M | 8%+1 | 8.5% |
2025 to 2034 revenue and share by line: Textiles and Apparel USD 175.1 million to USD 291.4 million (34% to 31%), Personal Care and Beauty USD 103 million to USD 197.4 million (20% to 21%), Automotive USD 61.8 million to USD 122.2 million (12% to 13%), Paints, Coatings and Inks USD 51.5 million to USD 94 million (10% to 10%), Packaging USD 46.35 million to USD 94 million (9% to 10%), Household and Industrial Cleaning USD 41.2 million to USD 65.8 million (8% to 7%), Pharmaceuticals and Food USD 36.05 million to USD 75.2 million (7% to 8%). Pharmaceuticals and Food Outpaces the Axis While Textiles and Apparel Holds the Largest Share Textiles and apparel lead because fibre production is the main outlet for bio-based propanediol and brand owners favour renewable content in fabrics and carpets. Pharmaceuticals and food grow fastest as natural-origin ingredient claims spread, qualification of new suppliers progresses, and demand for renewable solvents and carriers in regulated products builds. By 2034 Textiles and Apparel is still ahead, making this a shift in weight, not a change of leader.
By Product Positioning · 3 segments
Fully Bio-based PDO Held the Dominant Share of the Product positioning Segment in 2025
- Largest Fully Bio-based PDO · 70%
- Fastest Drop-in Replacement for Petro-based Glycols · 11.1%
- Moves most Drop-in Replacement for Petro-based Glycols · +5 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Fully Bio-based PDO | $361M | 70% | $620M | 66%-4 | 6.2% |
| Partially Bio-based PDO | $92.70M | 18% | $160M | 17%-1 | 6.2% |
| Drop-in Replacement for Petro-based Glycols | $61.80M | 12% | $160M | 17%+5 | 11.1% |
Fully bio-based product leads because most producers ferment renewable feedstock end to end and buyers use the bio-based content claim in marketing and in procurement rules. Drop-in replacement grows fastest as buyers look for a product that matches petro-based glycol specifications without reformulation, which lowers switching effort and speeds adoption in industrial uses. The order does not change: Fully Bio-based PDO is still largest in 2034, and what moves is how much it holds.
By Producer Type · 4 segments
Specialty Chemical Companies Outpaces the Axis While Integrated Joint Ventures Holds the Largest Share
- Largest Integrated Joint Ventures · 36%
- Fastest Specialty Chemical Companies · 8.5%
- Moves most Integrated Joint Ventures · -4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Integrated Joint Ventures | $185M | 36% | $301M | 32%-4 | 5.5% |
| Independent Bio-PDO Producers | $144M | 28% | $282M | 30%+2 | 7.7% |
| Corn Processors and Agri-industrial Producers | $113M | 22% | $207M | 22% | 6.9% |
| Specialty Chemical Companies | $72.10M | 14% | $150M | 16%+2 | 8.5% |
Integrated joint ventures lead because they pair fermentation technology with feedstock supply and large plants, which secures cost position and customer contracts. Independent bio-based producers grow fastest as new entrants add capacity and sell to regional buyers, and as specialty chemical companies and agri-industrial groups seek volume outside the established partnerships. The order does not change: Integrated Joint Ventures is still largest in 2034, and what moves is how much it holds.
By Production Capacity Band · 3 segments
By Production Capacity Band
- Largest 10,000 to 50,000 Tons per Year · 44%
- Fastest Above 50,000 Tons per Year · 8.9%
- Moves most Above 50,000 Tons per Year · +6 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Below 10,000 Tons per Year | $113M | 22% | $169M | 18%-4 | 4.6% |
| 10,000 to 50,000 Tons per Year | $227M | 44% | $395M | 42%-2 | 6.4% |
| Above 50,000 Tons per Year | $175M | 34% | $376M | 40%+6 | 8.9% |
Above 50,000 Tons per Year Outpaces the Axis While 10,000 to 50,000 Tons per Year Holds the Largest Share The middle capacity band leads because most operating plants are sized for regional fibre and cosmetic customers and balance scale against feedstock logistics. The largest band grows fastest as announced expansions come online, lowering unit cost and allowing producers to serve global polymer buyers from fewer sites, while small plants remain niche. 10,000 to 50,000 Tons per Year remains the largest line through 2034, so the axis changes in proportion, not in order.
By Sales Channel · 4 segments
Online and Catalogue Suppliers Outpaces the Axis While Direct Sales to Manufacturers Holds the Largest Share
- Largest Direct Sales to Manufacturers · 41%
- Fastest Online and Catalogue Suppliers · 8.8%
- Moves most Long-term Supply Contracts · +4 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Direct Sales to Manufacturers | $211M | 41% | $357M | 38%-3 | 6% |
| Chemical Distributors | $139M | 27% | $235M | 25%-2 | 6% |
| Online and Catalogue Suppliers | $30.90M | 6% | $65.80M | 7%+1 | 8.8% |
| Long-term Supply Contracts | $134M | 26% | $282M | 30%+4 | 8.6% |
Direct sales to manufacturers lead because polymer and fibre producers buy large volumes under specification and qualify suppliers directly. Online and catalogue suppliers grow fastest from a small base as laboratories, small formulators and start-ups buy small lots with simple ordering, and as more suppliers list grades with documentation online. The order does not change: Direct Sales to Manufacturers is still largest in 2034, and what moves is how much it holds.
By Packaging Form · 4 segments
Bulk Tanker Led by Packaging form in 2025, with Small Packs Growing Fastest
- Largest Bulk Tanker · 38%
- Fastest Small Packs · 9.6%
- Moves most Bulk Tanker · -2 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Bulk Tanker | $196M | 38% | $338M | 36%-2 | 6.3% |
| ISO Tank and IBC | $155M | 30% | $291M | 31%+1 | 7.3% |
| Drums | $124M | 24% | $216M | 23%-1 | 6.4% |
| Small Packs | $41.20M | 8% | $94M | 10%+2 | 9.6% |
Bulk tanker leads because polymer and industrial buyers take large volumes and unload straight into storage tanks, which cuts handling and packaging cost. Small packs grow fastest from a small base as cosmetic formulators, laboratories and small producers order low volumes of high-purity grades and as catalogue sales expand. Bulk Tanker remains the largest line through 2034, so the axis changes in proportion, not in order.
Regional Insights
Regional Revenue Share
Base year 2025Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The 2nd-largest region covered — 2 points of share move elsewhere by 2034, while revenue still grows 1.7×.
- Rank 2 of 5
- 2025 share 27%
- By 2034 25%
- Revenue $139M → $235M
USD 139.05 million of 2025 revenue is generated in North America, 27% of the global bio-based 1,3-propanediol market on the way to USD 235 million by 2034. Among the five regions it ranks second by revenue in both years.
Share settles at 25% in 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
Within the region the production technology split tracks the global one; 58% of 2025 revenue in Microbial Fermentation, fastest growth of 10.62% in Hybrid Bio-chemical Routes. Revenue for North America is broken out by every segmentation axis and by country in the full report.
United States
Sets the pace for North America at 87.7% of it, growing 1.7×.
- In region 1 of 2
- Of region 87.7%
- Of global 23.7%
- Revenue $122M → $207M
87.74% of North America's base-year revenue comes from the United States; USD 122 million, rising to USD 207 million by 2034. 87.74% of the region in 2025 means the regional figures are, in practice, a view of this market with others attached. Regional revenue of USD 139.05 million in 2025 and USD 235 million in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
the United States buys along the same lines as the market globally; Microbial Fermentation first at 58% of 2025 revenue and 52% in 2034, Hybrid Bio-chemical Routes fastest at 10.62% on a share moving from 8% to 11%. Because the country carries 87.74% of North America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-production technology revenue for the United States appears on its own in the full report.
Bio-based propanediol is a chemical substance, so the Environmental Protection Agency governs it under the Toxic Substances Control Act. A supplier must confirm the substance appears on the TSCA Inventory, or file a premanufacture notice before manufacture or import begins, and importers certify compliance at the border. Workplace communication falls under the Occupational Safety and Health Administration's Hazard Communication Standard, which calls for safety data sheets and hazard labels aligned with the Globally Harmonized System. Where the material goes into personal care products, the Food and Drug Administration oversees the safety and labelling of the finished goods. The USDA BioPreferred program offers a voluntary label for verified bio-based content.
In the United States the field is Primient Covation LLC, Zhangjiagang Glory Biomaterial Co., Ltd., DuPont de Nemours, Inc., Tate & Lyle PLC, Jiangsu Eastern Shenghong Co., Ltd., Guangdong Tsinghua Smart Biotech Co., Ltd., Zouping Mingxing Chemical Co., Ltd., Haihang Industry Co., Ltd., Shell plc, Far Eastern New Century Corporation, Croda International Plc, Evonik Industries AG, Symrise AG, Ashland Inc., Alzo International, Inc., Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific Inc., Brenntag SE, IMCD N.V., Univar Solutions LLC, Azelis Group NV and Barentz International B.V.. Two different problems sit on the same axis: holding Microbial Fermentation at 58% of 2025 revenue, and taking Hybrid Bio-chemical Routes while it grows at 10.62%. The full report covers country-level positioning and shares company by company; this summary does not.
Canada
2nd-largest in North America, growing 1.7×.
- In region 2 of 2
- Of region 8.3%
- Of global 2.2%
- Revenue $11.50M → $19.50M
Canada is sized at USD 11.5 million in 2025, rising to USD 19.5 million by 2034; 2.23% of global revenue and 8.27% of North America. It is reported separately from the United States across every segmentation axis in the full report.
Europe Market Analysis
The 3rd-largest region covered — 2 points of share move elsewhere by 2034, while revenue still grows 1.7×.
- Rank 3 of 5
- 2025 share 24%
- By 2034 22%
- Revenue $124M → $207M
USD 123.6 million of 2025 revenue is generated in Europe, 24% of the global bio-based 1,3-propanediol market and reaches USD 206.8 million by 2034. It is a leading region on this axis, third by revenue throughout the period.
Its share moves to 22% by 2034, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.
Segment composition follows the global pattern: Microbial Fermentation largest at 58% of 2025 revenue, Hybrid Bio-chemical Routes fastest at 10.62%. Revenue for Europe is broken out by every segmentation axis and by country in the full report.
Germany
The largest market in Europe, growing 1.7×.
- In region 1 of 3
- Of region 29.1%
- Of global 7%
- Revenue $36M → $60M
Germany is the largest market within Europe, generating USD 36 million in 2025 and projected to reach USD 60 million by 2034. At 29.13% of the region in 2025 it leads, but a majority of Europe's revenue is generated in other markets. Set against USD 123.6 million and USD 206.8 million for the region, it is why this market, and not a smaller one, is the one reported in full.
Germany buys along the same lines as the market globally; Microbial Fermentation first at 58% of 2025 revenue and 52% in 2034, Hybrid Bio-chemical Routes fastest at 10.62% on a share moving from 8% to 11%. Since 29.13% of Europe's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Revenue by production technology for Germany is reported separately in the full report.
Germany applies European Union chemicals law directly. A manufacturer or importer registers the substance with the European Chemicals Agency under REACH, supplying hazard and exposure data in proportion to the volume placed on the market. The CLP Regulation sets classification, labelling and packaging duties, and safety data sheets must follow the REACH format. The Federal Institute for Occupational Safety and Health acts as the national authority and coordinates enforcement with the state inspectorates. When the ingredient is used in cosmetics, the EU Cosmetics Regulation adds ingredient naming and safety assessment duties for the finished product. Bio-based claims are voluntary and normally rest on third-party certification.
In Germany the field is Primient Covation LLC, Zhangjiagang Glory Biomaterial Co., Ltd., DuPont de Nemours, Inc., Tate & Lyle PLC, Jiangsu Eastern Shenghong Co., Ltd., Guangdong Tsinghua Smart Biotech Co., Ltd., Zouping Mingxing Chemical Co., Ltd., Haihang Industry Co., Ltd., Shell plc, Far Eastern New Century Corporation, Croda International Plc, Evonik Industries AG, Symrise AG, Ashland Inc., Alzo International, Inc., Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific Inc., Brenntag SE, IMCD N.V., Univar Solutions LLC, Azelis Group NV and Barentz International B.V.. Microbial Fermentation, at 58% of 2025 revenue, is where the volume sits, and Hybrid Bio-chemical Routes, growing at 10.62%, is where position changes hands over the forecast period. The commercial size of that position is USD 123.6 million in 2025, moving to USD 206.8 million by 2034 across the forecast period.
France
2nd-largest in Europe, growing 1.7×.
- In region 2 of 3
- Of region 13.8%
- Of global 3.3%
- Revenue $17M → $29M
France is sized at USD 17 million in 2025, rising to USD 29 million by 2034; 3.3% of global revenue and 13.75% of Europe. It is reported separately from Germany across every segmentation axis in the full report.
Italy
3rd-largest in Europe, growing 1.7×.
- In region 3 of 3
- Of region 12.5%
- Of global 3%
- Revenue $15.50M → $26M
3.01% of global revenue is generated in Italy; USD 15.5 million in 2025, reaching USD 26 million in 2034, and 12.54% of Europe.
Asia Pacific Market Analysis
The largest region covered, and the one gaining the most — it picks up 5 points of share by 2034, while revenue still grows 2.1×.
- Rank 1 of 5
- 2025 share 38%
- By 2034 43%
- Revenue $196M → $404M
Asia Pacific holds 38% of the global bio-based 1,3-propanediol market in 2025, worth USD 195.7 million on the way to USD 404.2 million by 2034. It is a dominant region on this axis, first by revenue throughout the period.
43% of global revenue sits here by 2034, up from the 2025 level, so the region grows faster than the market's 6.95% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.
Within the region the production technology split tracks the global one; 58% of 2025 revenue in Microbial Fermentation, fastest growth of 10.62% in Hybrid Bio-chemical Routes. Asia Pacific is reported axis by axis and country by country in the full study.
China
The largest market in Asia Pacific, growing 2.2×.
- In region 1 of 3
- Of region 53.6%
- Of global 20.4%
- Revenue $105M → $233M
53.65% of Asia Pacific's base-year revenue comes from China; USD 105 million, rising to USD 233 million by 2034. Its 53.65% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Against regional totals of USD 195.7 million in 2025 and USD 404.2 million in 2034, it is the country the full report breaks out in detail.
Composition here matches the global split: the largest line is Microbial Fermentation at 58% of 2025 revenue, easing to 52% by 2034, and the fastest is Hybrid Bio-chemical Routes at 10.62%, from 8% to 11%. Its 53.65% weight in Asia Pacific means those movements carry straight into the regional totals. The full report reports China by production technology separately.
The Ministry of Ecology and Environment administers new chemical substances under the Measures for the Environmental Administration of New Chemical Substances. A substance missing from the Inventory of Existing Chemical Substances in China needs registration or filing before production or import, backed by physical, toxicological and ecological data. Hazardous chemicals fall under the Regulations on the Safety Management of Hazardous Chemicals, which require compliant safety data sheets and labels in Chinese. Where the ingredient enters cosmetics, the National Medical Products Administration expects the ingredient to be registered or filed, and the supplier to supply safety documentation to the brand owner.
In China the field is Primient Covation LLC, Zhangjiagang Glory Biomaterial Co., Ltd., DuPont de Nemours, Inc., Tate & Lyle PLC, Jiangsu Eastern Shenghong Co., Ltd., Guangdong Tsinghua Smart Biotech Co., Ltd., Zouping Mingxing Chemical Co., Ltd., Haihang Industry Co., Ltd., Shell plc, Far Eastern New Century Corporation, Croda International Plc, Evonik Industries AG, Symrise AG, Ashland Inc., Alzo International, Inc., Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific Inc., Brenntag SE, IMCD N.V., Univar Solutions LLC, Azelis Group NV and Barentz International B.V.. The commercially relevant division is 58% of 2025 revenue in Microbial Fermentation, where the volume is, against 10.62% growth in Hybrid Bio-chemical Routes, where share moves. The commercial size of that position is USD 195.7 million in 2025 and USD 404.2 million by 2034, 38% of the global total in the base year.
Japan
2nd-largest in Asia Pacific, growing 1.7×.
- In region 2 of 3
- Of region 14.3%
- Of global 5.4%
- Revenue $28M → $48M
Japan is sized at USD 28 million in 2025, rising to USD 48 million by 2034; 5.44% of global revenue and 14.31% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.
India
3rd-largest in Asia Pacific, growing 2.6×.
- In region 3 of 3
- Of region 7.4%
- Of global 2.8%
- Revenue $14.50M → $38M
2.82% of global revenue is generated in India; USD 14.5 million in 2025, reaching USD 38 million in 2034, and 7.41% of Asia Pacific.
Latin America Market Analysis
The 4th-largest region covered — 0.4 points of share move elsewhere by 2034, while revenue still grows 1.7×.
- Rank 4 of 5
- 2025 share 6%
- By 2034 5.6%
- Revenue $30.90M → $52.64M
Latin America holds 6% of the global bio-based 1,3-propanediol market in 2025, worth USD 30.9 million and reaches USD 52.64 million by 2034. By revenue it sits fourth across the study, and the ranking does not change between 2025 and 2034.
Share settles at 5.6% in 2034, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.
Within the region the production technology split tracks the global one; 58% of 2025 revenue in Microbial Fermentation, fastest growth of 10.62% in Hybrid Bio-chemical Routes. Revenue for Latin America is broken out by every segmentation axis and by country in the full report.
Brazil
The largest market in Latin America, growing 1.8×.
- In region 1 of 2
- Of region 50.2%
- Of global 3%
- Revenue $15.50M → $28.50M
Brazil is the largest market within Latin America, generating USD 15.5 million in 2025 and projected to reach USD 28.5 million by 2034. 50.16% of the region in the base year makes it the largest market here without making it the region. Against regional totals of USD 30.9 million in 2025 and USD 52.64 million in 2034, it is the country the full report breaks out in detail.
Composition here matches the global split: the largest line is Microbial Fermentation at 58% of 2025 revenue, easing to 52% by 2034, and the fastest is Hybrid Bio-chemical Routes at 10.62%, from 8% to 11%. Its 50.16% weight in Latin America means those movements carry straight into the regional totals. Brazil carries its own production technology breakdown in the full report.
Brazil has been building a national framework for industrial chemicals, with the environmental authority and the health regulator sharing oversight of inventory, notification and risk assessment duties. A supplier should confirm current requirements for registering a new substance before importing or producing it. Hazard classification and labelling follow the Globally Harmonized System as adopted through the Brazilian Association of Technical Standards, which governs safety data sheets and container labels in Portuguese. For cosmetic and personal care uses, the health regulator ANVISA sets ingredient rules and requires finished products to be notified or registered. Transport of chemical cargo is subject to separate dangerous goods rules.
Primient Covation LLC, Zhangjiagang Glory Biomaterial Co., Ltd., DuPont de Nemours, Inc., Tate & Lyle PLC, Jiangsu Eastern Shenghong Co., Ltd., Guangdong Tsinghua Smart Biotech Co., Ltd., Zouping Mingxing Chemical Co., Ltd., Haihang Industry Co., Ltd., Shell plc, Far Eastern New Century Corporation, Croda International Plc, Evonik Industries AG, Symrise AG, Ashland Inc., Alzo International, Inc., Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific Inc., Brenntag SE, IMCD N.V., Univar Solutions LLC, Azelis Group NV and Barentz International B.V. are the suppliers covered in Brazil. Volume sits in Microbial Fermentation at 58% of 2025 revenue; movement sits in Hybrid Bio-chemical Routes at 10.62% growth. A supplier weighted toward Latin America is competing over a base of USD 30.9 million in 2025 reaching USD 52.64 million by 2034, 6% of global revenue at the start of that period.
Mexico
2nd-largest in Latin America, growing 1.7×.
- In region 2 of 2
- Of region 19.4%
- Of global 1.2%
- Revenue $6M → $10M
Within Latin America, Mexico accounts for 19.42% of regional revenue and 1.17% of the global total, worth USD 6 million in 2025 and USD 10 million by 2034.
Middle East and Africa Market Analysis
The 5th-largest region covered — 0.6 points of share move elsewhere by 2034, while revenue still grows 1.6×.
- Rank 5 of 5
- 2025 share 5%
- By 2034 4.4%
- Revenue $25.75M → $41.36M
USD 25.75 million of 2025 revenue is generated in Middle East and Africa, 5% of the global bio-based 1,3-propanediol market and reaches USD 41.36 million by 2034. Among the five regions it ranks fifth by revenue in both years.
By 2034 the share stands at 4.4%, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.
Microbial Fermentation leads here as it does globally, at 58% of 2025 revenue, and Hybrid Bio-chemical Routes again grows fastest at 10.62%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.
Saudi Arabia
The largest market in Middle East and Africa, growing 1.8×.
- In region 1 of 2
- Of region 25.2%
- Of global 1.3%
- Revenue $6.50M → $11.50M
USD 6.5 million of Middle East and Africa's 2025 revenue is generated in Saudi Arabia, the region's largest market, reaching USD 11.5 million by 2034. 25.24% of the region in the base year makes it the largest market here without making it the region. Regional revenue of USD 25.75 million in 2025 and USD 41.36 million in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
Saudi Arabia buys along the same lines as the market globally; Microbial Fermentation first at 58% of 2025 revenue and 52% in 2034, Hybrid Bio-chemical Routes fastest at 10.62% on a share moving from 8% to 11%. With 25.24% of Middle East and Africa concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports Saudi Arabia by production technology separately.
Chemical imports are regulated through several agencies. The Saudi Standards, Metrology and Quality Organization runs the SABER platform, through which importers obtain a product conformity certificate before goods clear customs. The National Center for Environmental Compliance oversees chemical management and environmental permits, while safety data sheets and hazard labels follow the Globally Harmonized System, with Arabic text expected on supplied goods. Where the product is used in cosmetics or food contact applications, the Saudi Food and Drug Authority applies its own listing and registration requirements. Suppliers normally work with a local importer of record to handle these filings.
The suppliers tracked in this study (Primient Covation LLC, Zhangjiagang Glory Biomaterial Co., Ltd., DuPont de Nemours, Inc., Tate & Lyle PLC, Jiangsu Eastern Shenghong Co., Ltd., Guangdong Tsinghua Smart Biotech Co., Ltd., Zouping Mingxing Chemical Co., Ltd., Haihang Industry Co., Ltd., Shell plc, Far Eastern New Century Corporation, Croda International Plc, Evonik Industries AG, Symrise AG, Ashland Inc., Alzo International, Inc., Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific Inc., Brenntag SE, IMCD N.V., Univar Solutions LLC, Azelis Group NV and Barentz International B.V.) compete in Saudi Arabia across the production technology lines above. Microbial Fermentation, at 58% of 2025 revenue, is where the volume sits, and Hybrid Bio-chemical Routes, growing at 10.62%, is where position changes hands over the forecast period. A supplier weighted toward Middle East and Africa is competing over a base of USD 25.75 million in 2025, reaching USD 41.36 million by 2034 on the trajectory this study models.
South Africa
2nd-largest in Middle East and Africa, growing 1.6×.
- In region 2 of 2
- Of region 19.4%
- Of global 1%
- Revenue $5M → $8M
0.97% of global revenue is generated in South Africa; USD 5 million in 2025, reaching USD 8 million in 2034, and 19.42% of Middle East and Africa.
Download a free sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by production technology, feedstock, grade, purity level, application, end-use industry, product positioning, producer type, production capacity band, sales channel, packaging form, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Scale in Microbial Fermentation and Growth in Hybrid Bio-chemical Routes Set the Terms of Competition
Suppliers in scope: Primient Covation LLC, Zhangjiagang Glory Biomaterial Co., Ltd., DuPont de Nemours, Inc., Tate & Lyle PLC, Jiangsu Eastern Shenghong Co., Ltd., Guangdong Tsinghua Smart Biotech Co., Ltd., Zouping Mingxing Chemical Co., Ltd., Haihang Industry Co., Ltd., Shell plc, Far Eastern New Century Corporation, Croda International Plc, Evonik Industries AG, Symrise AG, Ashland Inc., Alzo International, Inc., Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific Inc., Brenntag SE, IMCD N.V., Univar Solutions LLC, Azelis Group NV and Barentz International B.V..
The competitive line that matters is the production technology one, not the geographic one. The largest block of revenue is Microbial Fermentation: USD 298.7 million in 2025 at 58% of the total, 52% in 2034. Incumbency there is expensive to challenge. Hybrid Bio-chemical Routes, compounding at 10.62% against 5.66% for Microbial Fermentation, is where share changes hands over the forecast period. A supplier positioned in one is not automatically positioned in the other, so a field of this size stays viable in a market of USD 515 million.
Suppliers separate on fermentation yield and strain performance, since feedstock conversion efficiency sets the cost position more than any other factor. Producers with integrated corn or sugar supply and large continuous plants hold a cost and reliability advantage, and polymer-grade buyers qualify them over long periods before committing volume. Cosmetic and food grades add purity certification and documentation requirements that favour suppliers with established regulatory files. Smaller and regional producers compete on local supply, shorter lead times, flexible lot sizes and specialty grades, while distributors serve fragmented demand in laboratory, industrial and personal care uses.
Presence matters unevenly by region. With 38% of 2025 revenue in Asia Pacific and 27% in North America, a supplier's coverage of those two decides most of its addressable base before any product question arises.
Company-level profiles, financials, shares and development histories are held in the full report and not in this summary.
List of Key Bio-based 1,3-Propanediol Market Companies Profiled
23 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- Primient Covation LLC(United States)
- Zhangjiagang Glory Biomaterial Co., Ltd.(China)
- DuPont de Nemours, Inc.(United States)
- Tate & Lyle PLC(United Kingdom)
- Jiangsu Eastern Shenghong Co., Ltd.(China)
- Guangdong Tsinghua Smart Biotech Co., Ltd.(China)
- Zouping Mingxing Chemical Co., Ltd.(China)
- Haihang Industry Co., Ltd.(China)
- Shell plc(United Kingdom)
- Far Eastern New Century Corporation(Taiwan)
- Croda International Plc(United Kingdom)
- Evonik Industries AG(Germany)
- Symrise AG(Germany)
- Ashland Inc.(United States)
- Alzo International, Inc.(United States)
- Merck KGaA(Germany)
- Tokyo Chemical Industry Co., Ltd.(Japan)
- Thermo Fisher Scientific Inc.(United States)
- Brenntag SE(Germany)
- IMCD N.V.(Netherlands)
- Univar Solutions LLC(United States)
- Azelis Group NV(Belgium)
- Barentz International B.V.(Netherlands)
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 11 axes (Production Technology, Feedstock, Grade, Purity Level, Application, End-use Industry, Product Positioning, Producer Type, Production Capacity Band, Sales Channel, Packaging Form), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 23 key companies, and the research methodology behind every estimate.
Segmentation
11 axes + regionQuestions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Bio-based 1,3-Propanediol Market projected to reach?
USD 940 USD Million by 2034, CAGR 6.95%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
Asia Pacific leads with 38% of global revenue through 2034.
05Which segment leads the market?
Microbial Fermentation is the largest line by production technology, at 58% of revenue in 2025.
06Who are the key companies profiled?
Primient Covation LLC, Zhangjiagang Glory Biomaterial Co., Ltd., DuPont de Nemours, Inc., Tate & Lyle PLC, Jiangsu Eastern Shenghong Co., Ltd., Guangdong Tsinghua Smart Biotech Co., Ltd., Zouping Mingxing Chemical Co., Ltd., Haihang Industry Co., Ltd., Shell plc, Far Eastern New Century Corporation, Croda International Plc, Evonik Industries AG, Symrise AG, Ashland Inc., Alzo International, Inc., Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific Inc., Brenntag SE, IMCD N.V., Univar Solutions LLC, Azelis Group NV, Barentz International B.V.. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.